Do you follow any other biotechs? You think that this announcement is going to create panic????? : "the recommendation to complete the Phase 2b trial indicates that the DSMC found no significant safety issues with aldoxorubicin, even though the dose of aldoxorubicin administered in this trial delivers doxorubicin at three-and-a-half times its standard dose". What exactly do you think a safety analysis is? Do you equate safety with efficacy? Can you think of other reasons why this drug might be safe? Why don't you put your thinking cap on and let us know one other reason why this drug might be safe, okay? Can you name a couple of other drugs that recently failed miserably after passing safety assessments?